MAUREEN LUPICA: Open Payments
NPI 1689001497 · NORTH SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 27 payments from 8 companies in 2025. Trend: 2023 $538 · 2024 $1,135 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $141 |
| Amgen Inc. | 11 | $141 |
| ANI Pharmaceuticals, Inc. | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Vantive US Healthcare LLC | 1 | $50 |
| Fresenius USA Marketing, Inc. | 1 | $20 |
| NxStage Medical, Inc. | 1 | $16 |
Products named: Ozempic, KRYSTEXXA, PURIFIED CORTROPHIN GEL, Kerendia, JYNARQUE, Renal - PD, VELPHORO, NXSTAGE SYSTEM ONE.
Industry payments across NY — which companies pay providers there.
